Effect of Kinesio Taping Versus Myofascial Release on Menstrual Low Back Pain

NCT ID: NCT06280989

Last Updated: 2025-02-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

44 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-04-15

Study Completion Date

2025-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

the aim of this study is to investigate the efficacy of kinesio taping versus myofascial release technique on menstrual low back pain in young females

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

: Menstrual low back pain is a prevalent condition among women. Menstrual low back pain occurrence is affected by hormonal changes. Menstrual low back pain incidence more than 40% to 50% during the menstrual phase (days 1-6) of the menstrual cycle, while the range of prevalence was 45 to 95%. It has a high prevalence among females, especially females aged 20 to 25 years old. Hormonal changes might play an important role in the formation of Menstrual low back pain and is the main cause of feeling of pain during menstrual cycle. kinesio taping and myofascial release technique play an important role in the treatment of Menstrual low back pain. this trial has two groups; one will receive kinesio taping three days and the second will receive myofascial release technique for12 sessions through 3 consecutive menstrual cycle

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Low Back Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

kinesio taping and myofascial release technique
Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

kinesio taping

Each female will be treated by Kinesio tape which will be applied for three days (from the first day to the end of the third day of menstrual cycle) throughout 3 consecutive cycles.

Group Type EXPERIMENTAL

kinesio taping

Intervention Type OTHER

Before treatment, all female participants will undergo an allergic test on the anterior surface of the elbow.

To ensure cleanliness, alcohol will be used to clean the areas to be evaluated before applying the tape. The H technique will be employed to apply KT over the lumbar region. Participants will be instructed to bend forwards from the waist, and two vertical strips will be applied. These strips will stretch the Golgi tendon organ on both sides of the spine from the top of the buttock cleft upwards to a mid-point, with less than 25% stretch .

Additionally, a horizontal strip will be attached across the left and right sacroiliac joints. This strip will be stretched to 50% of its maximum capacity,.

myofascial release technique

Each female will be treated by myofascial relaxation technique which will be started at the third or fourth day of menstruation and continued till the onset of the next menstruation, 40 minutes, 3 times / week for 12 sessions through 3 consecutive menstrual cycle

Group Type EXPERIMENTAL

myofascial release technique

Intervention Type OTHER

myofascial release technique will be applied from prone on lumbar paravertebral muscles by using the olecranon of the physical therapist for 3 minutes, thoracolumbar fascia by using cross-handed hold, with hands placed on the T12-L1 levels and on the sacrum for 5 minutes without repetition and quadratus lumborum by using elbow with low pressure obliquely towards the center of the column for 7 min.

Additionally, from supine on psoas muscle by transversal sliding of the psoas fascia. The therapist will place the hands laterally 3 cm from the umbilicus.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

kinesio taping

Before treatment, all female participants will undergo an allergic test on the anterior surface of the elbow.

To ensure cleanliness, alcohol will be used to clean the areas to be evaluated before applying the tape. The H technique will be employed to apply KT over the lumbar region. Participants will be instructed to bend forwards from the waist, and two vertical strips will be applied. These strips will stretch the Golgi tendon organ on both sides of the spine from the top of the buttock cleft upwards to a mid-point, with less than 25% stretch .

Additionally, a horizontal strip will be attached across the left and right sacroiliac joints. This strip will be stretched to 50% of its maximum capacity,.

Intervention Type OTHER

myofascial release technique

myofascial release technique will be applied from prone on lumbar paravertebral muscles by using the olecranon of the physical therapist for 3 minutes, thoracolumbar fascia by using cross-handed hold, with hands placed on the T12-L1 levels and on the sacrum for 5 minutes without repetition and quadratus lumborum by using elbow with low pressure obliquely towards the center of the column for 7 min.

Additionally, from supine on psoas muscle by transversal sliding of the psoas fascia. The therapist will place the hands laterally 3 cm from the umbilicus.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Healthy young virgin females suffering from menstrual low back pain diagnosed by the gynecologist.
2. Their ages will be ranged from 18-25 years\' old
3. Their body mass index will be ranged from 20-25 kg/m2.
4. All females have regular menstruation
5. Their pain intensity is scored as \> 4 on VAS just before or during the first 3 days of the menstruation

\-

Exclusion Criteria

Females will be excluded from the study if they have:

1. Any orthopedic problems such as trauma at lower spine, congenital malformation at spine and scoliosis.
2. Any gynecological problem such as irregular menstrual cycle, secondary dysmenorrhea due to endometriosis, ovarian cyst, uterine fibroid and congenital malformation or pelvic inflammation.
3. Athletic females
4. Allergy to kinesio taping.

\-
Minimum Eligible Age

18 Years

Maximum Eligible Age

25 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Cairo University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Hala Mohamed Ahmed Morsy

principle investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Manal El El shafei, lecture

Role: PRINCIPAL_INVESTIGATOR

Cairo University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hala mohamed ahmed morsy

Giza, Egypt, Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Hala ma Morsy, Bachelor

Role: CONTACT

0020-01028616865

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

hala ma morsy, Bachelor

Role: primary

00201028616865

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

P.T.REC/012/004768

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.